Author:
Cáceres Carlos F,Bekker Linda-Gail,Godfrey-Faussett Peter
Funder
UNAIDS
UPCH
Bill and Melinda Gates Foundation
JIAS
University of California
CONACyT
UC-MEXUS CONACyT postdoctoral research fellowship
UC San Diego CFAR center
National Institute of Allergy and Infectious Diseases
HIV Modelling Consortium at Imperial College London
Australian government Department of Health
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference502 articles.
1. World Health Organization Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV [Internet]. 2015 http://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/
2. If PrEP decreases HIV transmission, what is impeding its uptake?;Mayer;Clin Infect Dis.,2015
3. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.;McCormack;Lancet,2016
4. Mascolini M. Wider PrEP use in San Francisco could cut new HIV rate by 70% 22nd Conference on Retroviruses and Opportunistic Infections 2015 Seattle, WA
5. Molina J-M Capitant C Spire B Pialoux G Chidiac C Charreau I On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. Abstract 23 LB. 22nd Conference on Retroviruses and Opportunistic Infections 2015 Seattle, WA